Bipolar Disorder Trial, Recruiting NCT07121894 Sponsor: Mayo Clinic Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07121894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 50 years old
  • You are willing to switch to a high-fat, low-carbohydrate (ketogenic-style) diet
  • You have been diagnosed with Bipolar I disorder, Bipolar II disorder, or schizoaffective disorder (bipolar type), confirmed through a structured medical interview
  • You have at least mild depression symptoms and have been on a stable mood medication (such as lithium, valproate, or an antipsychotic) for at least 2 weeks
  • Your urine drug test comes back negative, except for any medications you have been prescribed (such as certain anti-anxiety medicines)
  • You have a negative pregnancy test
  • If you are sexually active, you are using a reliable form of birth control
  • Any other health conditions you have (such as high blood pressure or type 2 diabetes) are currently stable and well-managed

Who may not be able to join:

  • You do not have access to a smartphone or the internet (unless the study provides one for you)
  • You are unable or unwilling to give written consent, or you cannot pass a basic quiz (scoring at least 80%) about what the study involves
  • You have a confirmed diagnosis of schizophrenia or are currently experiencing psychotic symptoms
  • You have a personality disorder that is considered your main psychiatric diagnosis, based on a review by the study psychiatrist
  • You are currently experiencing a mix of depression and high-energy (hypomanic) symptoms at the same time
  • You are currently having thoughts of suicide with any intention or plan
  • You currently have a drug or alcohol use disorder (not including nicotine); you may qualify if you have been fully in recovery for 3 or more months
  • You test positive for cannabis use and are found to have a cannabis use disorder (though you may still be considered if your cannabis use score is below a certain threshold — confirm with trial site)
  • You are currently receiving electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or deep brain stimulation as a treatment
  • You are currently held in a psychiatric facility against your will
  • Your body is already in a state of ketosis, or you are taking a medication that causes a related condition called acidosis (such as topiramate or acetazolamide)
  • Your BMI is below 18.5 (considered underweight), or your "bad" cholesterol (LDL) level is above 190
  • You have any active or unstable medical condition that the study doctor considers too risky, such as a serious ongoing infection
  • You have had pancreatitis (inflammation of the pancreas) or a history of it linked to high fat levels in the blood
  • You have Type 1 diabetes
  • You are taking a type of diabetes medication called an SGLT2 inhibitor
  • You have a rare inherited condition affecting how your body processes fats (such as Pyruvate carboxylase deficiency or Porphyria) — these are usually diagnosed in infancy (confirm with trial site)
  • You have a condition called primary carnitine deficiency
  • You have serious kidney disease or are on dialysis
  • You have a severe vitamin D deficiency based on a blood test
  • You have been diagnosed with low bone density (osteopenia) or have had a fragility fracture (a bone break from a minor injury)
  • You have significantly abnormal results on routine lab tests
  • You are planning to have a non-emergency surgery within the next 18 weeks
  • A close male relative (father or brother) had a heart attack or stroke before age 55, or a close female relative (mother or sister) had one before age 65
  • You have a personal or family history of a condition causing very high cholesterol, or your cholesterol or triglyceride levels are above certain thresholds
  • You have a history of heart disease, blocked arteries in the heart, or significant calcium deposits in your coronary arteries
  • You have had a stroke caused by a blocked blood vessel, or an ultrasound has found plaque buildup in the arteries in your neck
  • You have a history of blocked arteries in your legs or elsewhere in your body
  • You have a history of or currently have serious breathing problems where your blood oxygen levels are dangerously low
  • You have liver failure or serious ongoing liver disease, shown by very abnormal liver blood test results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kyla M. Lara-Breitinger, MD, Mayo Clinic

Phone: 507-293-3876

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
12 August 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in depressive symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov